In this video from the virtual European Society of Cataract and Refractive Surgeons winter meeting, Nino Hirnschall, MD, PhD, speaks about the potential advantages of Descemet’s stripping only.
Patient selection is crucial, as is the administration of Rho kinase inhibitors to modulate corneal endothelial cell regeneration.